Xu F, Liu D, Nunes MR, DA Rosa AP, Tesh RB, Xiao SY, 2007. Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). Am J Trop Med Hyg 76: 1194–1200.
Daubney R, Hudson JR, Garnham PC, 1931. Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle, and man from east Africa. J Pathol Bacteriol 34: 545–579.
Faye O, Diallo M, Diop D, Bezeid OE, Bâ H, Niang M, Dia I, Mohamed SA, Ndiaye K, Diallo D, Ly PO, Diallo B, Nabeth P, Simon F, Lô B, Diop OM, 2007. Rift Valley fever outbreak with east-central African virus lineage in Mauritania, 2003. Emerg Infect Dis 13: 1016–1024. Available at: http://www.cdc.gov/EID/content/13/7/1016.htm. Accessed August 10, 2008.
Ringot D, Durand J-P, Tolou H, Boutin J-P, Davoust B, 2004. Rift Valley fever in Chad. Emerg Infect Dis 10: 945–957.
Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH, 1979. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg 73: 630–633.
Van Velden DJ, Meyer JD, Olivier J, Gear JH, McIntosh B, 1977. Rift Valley fever affecting humans in South Africa: a clinicopathlogical study. S Afr Med J 51: 867–871.
Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, Turkistani AM, Al-Sayed MO, Abodahish Abdullah A, Khan AS, Ksiazek TG, Shobokshi O, 2003. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 37: 1084–1092.
Al-Hazmi A, Al-Rajhi AA, Abboud EB, Ayoola EA, Al-Hazmi M, Saadi R, Ahmed N, 2005. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology 112: 313–318.
Elwan MS, Sharaf MH, Gameel K, El-Hadi E, Arthur RR, 1997. Rift Valley fever retinopathy: observations in a new outbreak. Ann Saudi Med 17: 377–380.
Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ, 1999. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 285: 397–400.
Jup PG, Kemp A, Grobbelaar A, Lema P, Burt FJ, Alahmed AM, Al Mujalli D, Al Khamees M, Swanepoel R, 2002. The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies. Med Vet Entomol 16: 245–252.
Flick R, Bouloy M, 2005. Rift Valley fever virus. Curr Mol Med 5: 827–834.
Chambers PG, Swanopoel R, 1980. Rift Valley fever in abattoir workers. Cent Afr J Med 26: 122–126.
McIntosh BM, Russell D, Dos Santos I, Gears JHS, 1980. Rift Valley fever in humans in South Africa. S Afr Med J 58: 803–806.
Brown JL, Domininik JW, Morrissey RL, 1981. Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus. Infect Immun 33: 848–853.
Swanapoel R, Coetzer JA, 1994. Rift Valley fever. Royal Society (Great Britain), ed. Infectious Diseases of Livestock with Special Reference to Southern Africa. Volume 1. New York: Oxford University Press.
Smithburn KC, Mahaffy AF, Haddow AJ, Kitchen SF, Smith JF, 1949. Rift Valley fever: accidental infections among laboratory workers. J Immunol 62: 213–227.
Imam IZ, Darwish MA, El-Karamany R, 1979. An epidemic of Rift Valley fever in Egypt. Diagnosis of Rift Valley fever in man. Bull World Health Organ 57: 437–439.
Woods CW, Karpati AM, Grein T, McCarthy N, Gaturuku P, Muchiri E, Dunster L, Henderson A, Khan AS, Swanepoel R, Bonmarin I, Martin L, Mann P, Smoak BL, Ryan M, Ksiazek TG, Arthur RR, Ndikuyeze A, Agata NN, Peters CJ, 2002. An outbreak of Rift Valley fever in Northeastern Kenya, 1997–1998. Emerg Infect Dis 8: 138–144.
Abdo-Salem S, Gerbier G, Bonnet P, AL-Qadasi M, Tran A, Thiry E, AL-Eryni G, Roger F, 2006. Descriptive and spatial epidemiology of Rift Valley fever outbreak in Yemen 2000–2001. Ann NY Acad Sci 1081: 240–242.
Meegan JM, 1979. The Rift Valley fever epizootic in Egypt 1977–1978: description of the epizootic and virological studies. Trans R Soc Trop Med Hyg 73: 618–623.
Shoemaker T, Boulianne C, Vincent MJ, Pezzanite L, Al-Qahtani MM, Al-Mazrou Y, Khan AS, Rollin PE, Swanepoel R, Ksiazek TG, Nichol ST, 2002. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000–2001. Emerg Infect Dis 8: 1415–1420.
US Centers for Disease Control and Prevention (CDC), 2000. Outbreak of Rift Valley fever–Yemen, August–October 2000. MMWR Morb Mortal Wkly Rep 49: 1065–1066.
Nguku P, Sharif SK, Mutonga D, Amwayi S, Omollo J, Mohammed O, Farnon EC, Gould LH, Lederman E, Rao C, Sang R, Schnabel D, Feikin DR, Hightower A, Njenga MK, Breiman RF, 2010. An investigation of a major outbreak of Rift Valley fever in Kenya: 2006–2007. Am J Trop Med Hyg 83 (Suppl 2): 5–13.
WHO, 2007; Epidemic and Pandemic Alert and Response (EPR). Rift Valley fever in Kenya, Somalia, and the United Republic of Tanzania. Available at: http://www.who.int/csr/don/2007_05_09/en/index.html. Accessed July 29, 2008.
Mohamed M, Mghamba FMJ, Zaki SR, Shieh W-J, Paweska J, Omulo S, Gikundi S, Mmbuji P, Bloland P, Zeidner N, Kalinga R, Breiman RF, Njenga MK, 2010. Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg 83 (Suppl 2): 22–27.
US Centers for Disease Control and Prevention (CDC), 2007. Rift Valley fever outbreak–Kenya, November 2006–January 2007. MMWR Morb Mortal Wkly Rep 56: 73–76.
Njenga MK, Traicoff D, Tetteh C, Likimani S, Oundo J, Breiman RF, Nyamongo J, Burke H, Nsubuga P, White M, 2008. Laboratory epidemiologist: skilled partner in field epidemiology and disease surveillance in Kenya. J Public Health Policy 29: 149–164.
Paweska JT, Burt FJ, Swanepoel R, 2005. Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans. J Virol Methods 124: 173–181.
Drosten C, Göttig S, Schiling S, Asper M, Panning M, Schmitz H, Gunther S, 2002. Rapid detection and quanititation of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcriptase-PCR. J Clin Microbiol 40: 2323–2330.
Hennekens CH, Buring JE, 1987. Epidemiology in medicine. Mayrent SL, ed. Measure of Disease Frequency and Association. First edition. Philadelphia, PA: Lippincott Williams & Wilkins, 54–98.
LaBeaud AD, Muchiri EM, Ndzovu M, Mwanje MT, Muiruri S, Peters CJ, King CH, 2008. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya. Emerg Infect Dis 1240–1246.
Davies FG, 2006. Risk of a Rift Valley fever epidemic at the haj in Mecca, Saudi Arabia. Rev Sci Tech 25: 137–147.
Frank SA, Jeffrey JS, 2001. The probability of severe disease in zoonotic and commensal infections. Proc Biol Sci 268: 53–60.
Asabe S, Wieland SF, Chattopadhyay PK, Roederer M, Engle RE, Purcell RH, Chisari FV, 2009. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol 83: 9652–9662.
Kimblin N, Peters N, Debrabant A, Secundino N, Egen J, Lawyer P, Fay MP, Kamhawi S, Sacks D, 2008. Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc Natl Acad Sci USA 105: 10125–10130.
Karmali MA, 2009. Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome. Kidney Int Suppl 112: S4–S7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19180132. Accessed May 18, 2010.
Ellis WA, 1998. Leptospirosis. In: Zoonoses, Plamer SR, Soulsby L, Simpson DIH, eds. Oxford: Oxford University Press, 115–126.
Monath TP, 1998. Yellow fever. In: Zoonoses Plamer SR, Soulsby L, Simpson DIH, eds. Oxford: Oxford University Press, 487–498.
Sang R, Kioko E, Lutomiah J, Warigia M, Ochieng C, O'Guinn M, Lee JS, Koka H, Godsey M, Hoel D, Hanafi H, Miller B, Schnabel D, Breiman RF, Richardson J, 2010. Rift Valley fever virus epidemic in Kenya, 2006/2007: the entomologic investigations. Am J Trop Med Hyg 83 (Suppl 2): 28–37.
Joubert JD, Ferguson AL, Gear JH, 1951. Rift Valley fever in South Africa: 2. The occurrence of human cases in the Orange Free State, the north-western Cape province, the western and southern Transvaal. A. Epidemiological and clinical findings. S Afr Med J 25: 890–891.
Jouan A, Coulibaly I, Adam F, Philippe B, Riou O, Leguenno B, Christie R, Ould Merzoug N, Ksiazek T, Digoutte JP, 1989. Analytical study of a Rift Valley fever epidemic. Res Virol 140: 175–186.
Abu-Elyazeed R, el-Sharkawy S, Olson J, Botros B, Soliman A, Salib A, Cummings C, Arthur R, 1996. Prevalence of anti-Rift Valley fever IgM antibody in abattoir workers in the Nile Delta during the 1993 outbreak in Egypt. Bull World Health Organ 74: 155–158.
Mundel B, Gear J, 1951. Rift Valley fever. I. The occurrence of human cases in Johannesburg. S Afr Med J 25: 926–930.
Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS, Rollin PE, Ksiazek TG, Nichol ST, Mahy BW, Peters CJ, 1995. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Pathol 146: 552–579.
WHO, 2003.Communicable Disease Surveillance & Response (CSR). Rift Valley fever in Egypt. Disease Outbreak Reported. Available at: http://www.who.int/csr/don/2003_09_02a/en/. Accessed August 29, 2008.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1622 | 1360 | 501 |
Full Text Views | 882 | 26 | 1 |
PDF Downloads | 331 | 30 | 1 |
A large Rift Valley fever (RVF) outbreak occurred in Kenya from December 2006 to March 2007. We conducted a study to define risk factors associated with infection and severe disease. A total of 861 individuals from 424 households were enrolled. Two hundred and two participants (23%) had serologic evidence of acute RVF infection. Of these, 52 (26%) had severe RVF disease characterized by hemorrhagic manifestations or death. Independent risk factors for acute RVF infection were consuming or handling products from sick animals (odds ratio [OR] = 2.53, 95% confidence interval [CI] = 1.78–3.61, population attributable risk percentage [PAR%] = 19%) and being a herdsperson (OR 1.77, 95% CI = 1.20–2.63, PAR% = 11%). Touching an aborted animal fetus was associated with severe RVF disease (OR = 3.83, 95% CI = 1.68–9.07, PAR% = 14%). Consuming or handling products from sick animals was associated with death (OR = 3.67, 95% CI = 1.07–12.64, PAR% = 47%). Exposures related to animal contact were associated with acute RVF infection, whereas exposures to mosquitoes were not independent risk factors.
Financial support: This work was supported by the Ministry of Public Health and Sanitation, Kenya; Centers for Disease Control and Prevention, Atlanta, GA and Nairobi, Kenya; Walter Reed Programme (WRP) U.S. Army Medical Research Unit, Kenya; Kenya Medical Research Institute (KEMRI), Kenya.
Authors' addresses: Amwayi S. Anyangu, Ministry of Public Health and Sanitation, Kenya, Provincial Headquarters North Eastern Province, Garissa, Kenya, E-mail: amwayi2004@yahoo.com. L. Hannah Gould, Centers for Disease Control and Prevention, Atlanta GA, E-mail: lgould@cdc.gov. Shahnaaz K. Sharif, Ministry of Public Health and Sanitation, Nairobi, Kenya, E-mails: sksharif@africaonline.co.ke or pphs@health.go.ke. Patrick M. Nguku, Division of Communicable Disease Control, Ministry of Health, Nairobi-Kenya, E-mail: drnguku@yahoo.com. Jared O. Omolo and David Mutonga, Division of Disease Surveillance and Response, Ministry of Health, Kenya, Nairobi, E-mails: jaredom@gmail.com and davidmutonga@yahoo.com. Carol Y. Rao, Division of Healthcare Quality Promotion Centers for Disease Control and Prevention, Atlanta, GA, E-mail: cnr3@cdc.gov. Edith R. Lederman, Poxvirus and Rabies Branch, Division of Viral and Rickettisial Diseases, National Center for Zoonotic, Vector-borne and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA, E-mails: dvk9@cdc.gov, erlederman@yahoo.com, or Edith.Lederman@med.navy.mil. David Schnabel, U.S. Army, Medical Corps, Global Emerging Infections System (GEIS), U.S. Army Medical Research Unit – Kenya, E-mail: dschnabel@wrp-nbo.org. Janusz T. Paweska, Special Pathogens Unit, National Institute for Communicable Diseases, South Africa. Mark Katz, Global Disease Detection Division CDC-Kenya, Nairobi, Kenya, E-mail: mkatz@ke.cdc.gov. Allen Hightower, CDC, Kenya, E-mail: AHightower@ke.cdc.gov. M. Kariuki Njenga, GDD/IEIP-Kenya, Centers for Disease Control, E-mail: KNjenga@ke.cdc.gov. Daniel R. Feikin, International Emerging Infections Program – Kenya, Centers for Disease Control and Prevention, U.S. Public Health Service, E-mail: DFeikin@ke.cdc.gov. Robert F. Breiman, Global Disease Detection Division, International Emerging Infections Program, CDC-Kenya, Nairobi, Kenya, E-mail: RBreiman@ke.cdc.gov.
Xu F, Liu D, Nunes MR, DA Rosa AP, Tesh RB, Xiao SY, 2007. Antigenic and genetic relationships among Rift Valley fever virus and other selected members of the genus Phlebovirus (Bunyaviridae). Am J Trop Med Hyg 76: 1194–1200.
Daubney R, Hudson JR, Garnham PC, 1931. Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle, and man from east Africa. J Pathol Bacteriol 34: 545–579.
Faye O, Diallo M, Diop D, Bezeid OE, Bâ H, Niang M, Dia I, Mohamed SA, Ndiaye K, Diallo D, Ly PO, Diallo B, Nabeth P, Simon F, Lô B, Diop OM, 2007. Rift Valley fever outbreak with east-central African virus lineage in Mauritania, 2003. Emerg Infect Dis 13: 1016–1024. Available at: http://www.cdc.gov/EID/content/13/7/1016.htm. Accessed August 10, 2008.
Ringot D, Durand J-P, Tolou H, Boutin J-P, Davoust B, 2004. Rift Valley fever in Chad. Emerg Infect Dis 10: 945–957.
Laughlin LW, Meegan JM, Strausbaugh LJ, Morens DM, Watten RH, 1979. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans R Soc Trop Med Hyg 73: 630–633.
Van Velden DJ, Meyer JD, Olivier J, Gear JH, McIntosh B, 1977. Rift Valley fever affecting humans in South Africa: a clinicopathlogical study. S Afr Med J 51: 867–871.
Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, Turkistani AM, Al-Sayed MO, Abodahish Abdullah A, Khan AS, Ksiazek TG, Shobokshi O, 2003. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis 37: 1084–1092.
Al-Hazmi A, Al-Rajhi AA, Abboud EB, Ayoola EA, Al-Hazmi M, Saadi R, Ahmed N, 2005. Ocular complications of Rift Valley fever outbreak in Saudi Arabia. Ophthalmology 112: 313–318.
Elwan MS, Sharaf MH, Gameel K, El-Hadi E, Arthur RR, 1997. Rift Valley fever retinopathy: observations in a new outbreak. Ann Saudi Med 17: 377–380.
Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ, 1999. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 285: 397–400.
Jup PG, Kemp A, Grobbelaar A, Lema P, Burt FJ, Alahmed AM, Al Mujalli D, Al Khamees M, Swanepoel R, 2002. The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies. Med Vet Entomol 16: 245–252.
Flick R, Bouloy M, 2005. Rift Valley fever virus. Curr Mol Med 5: 827–834.
Chambers PG, Swanopoel R, 1980. Rift Valley fever in abattoir workers. Cent Afr J Med 26: 122–126.
McIntosh BM, Russell D, Dos Santos I, Gears JHS, 1980. Rift Valley fever in humans in South Africa. S Afr Med J 58: 803–806.
Brown JL, Domininik JW, Morrissey RL, 1981. Respiratory infectivity of a recently isolated Egyptian strain of Rift Valley fever virus. Infect Immun 33: 848–853.
Swanapoel R, Coetzer JA, 1994. Rift Valley fever. Royal Society (Great Britain), ed. Infectious Diseases of Livestock with Special Reference to Southern Africa. Volume 1. New York: Oxford University Press.
Smithburn KC, Mahaffy AF, Haddow AJ, Kitchen SF, Smith JF, 1949. Rift Valley fever: accidental infections among laboratory workers. J Immunol 62: 213–227.
Imam IZ, Darwish MA, El-Karamany R, 1979. An epidemic of Rift Valley fever in Egypt. Diagnosis of Rift Valley fever in man. Bull World Health Organ 57: 437–439.
Woods CW, Karpati AM, Grein T, McCarthy N, Gaturuku P, Muchiri E, Dunster L, Henderson A, Khan AS, Swanepoel R, Bonmarin I, Martin L, Mann P, Smoak BL, Ryan M, Ksiazek TG, Arthur RR, Ndikuyeze A, Agata NN, Peters CJ, 2002. An outbreak of Rift Valley fever in Northeastern Kenya, 1997–1998. Emerg Infect Dis 8: 138–144.
Abdo-Salem S, Gerbier G, Bonnet P, AL-Qadasi M, Tran A, Thiry E, AL-Eryni G, Roger F, 2006. Descriptive and spatial epidemiology of Rift Valley fever outbreak in Yemen 2000–2001. Ann NY Acad Sci 1081: 240–242.
Meegan JM, 1979. The Rift Valley fever epizootic in Egypt 1977–1978: description of the epizootic and virological studies. Trans R Soc Trop Med Hyg 73: 618–623.
Shoemaker T, Boulianne C, Vincent MJ, Pezzanite L, Al-Qahtani MM, Al-Mazrou Y, Khan AS, Rollin PE, Swanepoel R, Ksiazek TG, Nichol ST, 2002. Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000–2001. Emerg Infect Dis 8: 1415–1420.
US Centers for Disease Control and Prevention (CDC), 2000. Outbreak of Rift Valley fever–Yemen, August–October 2000. MMWR Morb Mortal Wkly Rep 49: 1065–1066.
Nguku P, Sharif SK, Mutonga D, Amwayi S, Omollo J, Mohammed O, Farnon EC, Gould LH, Lederman E, Rao C, Sang R, Schnabel D, Feikin DR, Hightower A, Njenga MK, Breiman RF, 2010. An investigation of a major outbreak of Rift Valley fever in Kenya: 2006–2007. Am J Trop Med Hyg 83 (Suppl 2): 5–13.
WHO, 2007; Epidemic and Pandemic Alert and Response (EPR). Rift Valley fever in Kenya, Somalia, and the United Republic of Tanzania. Available at: http://www.who.int/csr/don/2007_05_09/en/index.html. Accessed July 29, 2008.
Mohamed M, Mghamba FMJ, Zaki SR, Shieh W-J, Paweska J, Omulo S, Gikundi S, Mmbuji P, Bloland P, Zeidner N, Kalinga R, Breiman RF, Njenga MK, 2010. Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hyg 83 (Suppl 2): 22–27.
US Centers for Disease Control and Prevention (CDC), 2007. Rift Valley fever outbreak–Kenya, November 2006–January 2007. MMWR Morb Mortal Wkly Rep 56: 73–76.
Njenga MK, Traicoff D, Tetteh C, Likimani S, Oundo J, Breiman RF, Nyamongo J, Burke H, Nsubuga P, White M, 2008. Laboratory epidemiologist: skilled partner in field epidemiology and disease surveillance in Kenya. J Public Health Policy 29: 149–164.
Paweska JT, Burt FJ, Swanepoel R, 2005. Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans. J Virol Methods 124: 173–181.
Drosten C, Göttig S, Schiling S, Asper M, Panning M, Schmitz H, Gunther S, 2002. Rapid detection and quanititation of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcriptase-PCR. J Clin Microbiol 40: 2323–2330.
Hennekens CH, Buring JE, 1987. Epidemiology in medicine. Mayrent SL, ed. Measure of Disease Frequency and Association. First edition. Philadelphia, PA: Lippincott Williams & Wilkins, 54–98.
LaBeaud AD, Muchiri EM, Ndzovu M, Mwanje MT, Muiruri S, Peters CJ, King CH, 2008. Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya. Emerg Infect Dis 1240–1246.
Davies FG, 2006. Risk of a Rift Valley fever epidemic at the haj in Mecca, Saudi Arabia. Rev Sci Tech 25: 137–147.
Frank SA, Jeffrey JS, 2001. The probability of severe disease in zoonotic and commensal infections. Proc Biol Sci 268: 53–60.
Asabe S, Wieland SF, Chattopadhyay PK, Roederer M, Engle RE, Purcell RH, Chisari FV, 2009. The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol 83: 9652–9662.
Kimblin N, Peters N, Debrabant A, Secundino N, Egen J, Lawyer P, Fay MP, Kamhawi S, Sacks D, 2008. Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies. Proc Natl Acad Sci USA 105: 10125–10130.
Karmali MA, 2009. Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome. Kidney Int Suppl 112: S4–S7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19180132. Accessed May 18, 2010.
Ellis WA, 1998. Leptospirosis. In: Zoonoses, Plamer SR, Soulsby L, Simpson DIH, eds. Oxford: Oxford University Press, 115–126.
Monath TP, 1998. Yellow fever. In: Zoonoses Plamer SR, Soulsby L, Simpson DIH, eds. Oxford: Oxford University Press, 487–498.
Sang R, Kioko E, Lutomiah J, Warigia M, Ochieng C, O'Guinn M, Lee JS, Koka H, Godsey M, Hoel D, Hanafi H, Miller B, Schnabel D, Breiman RF, Richardson J, 2010. Rift Valley fever virus epidemic in Kenya, 2006/2007: the entomologic investigations. Am J Trop Med Hyg 83 (Suppl 2): 28–37.
Joubert JD, Ferguson AL, Gear JH, 1951. Rift Valley fever in South Africa: 2. The occurrence of human cases in the Orange Free State, the north-western Cape province, the western and southern Transvaal. A. Epidemiological and clinical findings. S Afr Med J 25: 890–891.
Jouan A, Coulibaly I, Adam F, Philippe B, Riou O, Leguenno B, Christie R, Ould Merzoug N, Ksiazek T, Digoutte JP, 1989. Analytical study of a Rift Valley fever epidemic. Res Virol 140: 175–186.
Abu-Elyazeed R, el-Sharkawy S, Olson J, Botros B, Soliman A, Salib A, Cummings C, Arthur R, 1996. Prevalence of anti-Rift Valley fever IgM antibody in abattoir workers in the Nile Delta during the 1993 outbreak in Egypt. Bull World Health Organ 74: 155–158.
Mundel B, Gear J, 1951. Rift Valley fever. I. The occurrence of human cases in Johannesburg. S Afr Med J 25: 926–930.
Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS, Rollin PE, Ksiazek TG, Nichol ST, Mahy BW, Peters CJ, 1995. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am J Pathol 146: 552–579.
WHO, 2003.Communicable Disease Surveillance & Response (CSR). Rift Valley fever in Egypt. Disease Outbreak Reported. Available at: http://www.who.int/csr/don/2003_09_02a/en/. Accessed August 29, 2008.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1622 | 1360 | 501 |
Full Text Views | 882 | 26 | 1 |
PDF Downloads | 331 | 30 | 1 |